Page 3 - Unity Biotechnology Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unity biotechnology daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unity Biotechnology Daily Today - Breaking & Trending Today

Unity Biotechnology (NASDAQ:UBX) Given New $6.00 Price Target at Citigroup

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price target upped by Citigroup from $5.00 to $6.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on the company. Wedbush decreased their target price on Unity Biotechnology from $35.00 to $5.00 and set an outperform rating on the […] ....

United Kingdom General , United Kingdom , Jan Van Deursen , Judith Campisi , Nathaniel Eames David , Blackrock Inc , Unity Biotechnology Inc , Arete Wealth Advisors , Unity Biotechnology Company Profile , Geode Capital Management , Unity Biotechnology , Get Rating , Wealth Advisors , Street Corp , Capital Management , Sigma Investments , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Boost Price Target , Citigroup Inc ,

Unity Biotechnology, Inc. (NASDAQ:UBX) Short Interest Update

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 952,200 shares, a drop of 17.2% from the April 30th total of 1,150,000 shares. Based on an average daily trading volume, of 417,800 shares, the days-to-cover ratio […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Virtu Financial , Capital Investment Advisors , Schonfeld Strategic Advisors , Unity Biotechnology Inc , Unity Biotechnology , Get Rating , Sigma Investments , Street Group , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx ,

Citigroup Boosts Unity Biotechnology (NASDAQ:UBX) Price Target to $6.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective boosted by Citigroup from $5.00 to $6.00 in a research report sent to investors on Friday morning, The Fly reports. Several other research firms also recently commented on UBX. Mizuho dropped their price objective on shares of Unity Biotechnology from $12.00 to $6.00 and set […] ....

Jan Van Deursen , Nathaniel Eames David , Judith Campisi , Unity Biotechnology Inc , Unity Biotechnology Company Profile , Virtu Financial , Capital Investment Advisors , Schonfeld Strategic Advisors , Unity Biotechnology , Get Rating , Sigma Investments , Street Group , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Boost Price Target , Citigroup Inc ,

Wedbush Analysts Lift Earnings Estimates for Unity Biotechnology, Inc. (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities researchers at Wedbush increased their Q2 2023 earnings per share (EPS) estimates for shares of Unity Biotechnology in a note issued to investors on Monday, May 15th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($0.70) per share for the quarter, up from […] ....

Jan Van Deursen , Nathaniel Eames David , Judith Campisi , Arete Wealth Advisors , Parkman Healthcare Partners , Unity Biotechnology Inc , Maven Securities , Unity Biotechnology , Get Rating , Healthcare Partners , Wealth Advisors , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Earnings Estimates ,

FY2026 Earnings Forecast for Unity Biotechnology, Inc. Issued By Wedbush (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities research analysts at Wedbush cut their FY2026 earnings per share (EPS) estimates for Unity Biotechnology in a research report issued to clients and investors on Tuesday, April 25th. Wedbush analyst A. Argyrides now forecasts that the company will earn ($13.02) per share for the year, down […] ....

Nathaniel Eames David , Judith Campisi , Jan Van Deursen , Acadian Asset Management , Unity Biotechnology Company Profile , Renaissance Technologies , Unity Biotechnology Inc , Virtu Financial , Unity Biotechnology , Get Rating , Asset Management , Street Corp , Exoduspoint Capital Management , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Earnings Estimates ,